相似文献
1
Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer.
Mol Oncol. 2008 Oct;2(3):250-60. doi: 10.1016/j.molonc.2008.07.001. Epub 2008 Jul 22.
2
Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.
Mol Oncol. 2011 Feb;5(1):48-60. doi: 10.1016/j.molonc.2010.08.002. Epub 2010 Aug 11.
3
Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression.
Clin Chem. 2013 Jan;59(1):296-305. doi: 10.1373/clinchem.2012.193060. Epub 2012 Nov 7.
4
Parallel overexpression of seven kallikrein genes in ovarian cancer.
Cancer Res. 2003 May 1;63(9):2223-7.
5
Integrated genomic characterization of the kallikrein gene locus in cancer.
Anticancer Res. 2012 Mar;32(3):957-63.
6
A computational analysis of the genetic and transcript diversity at the kallikrein locus.
Biol Chem. 2016 Dec 1;397(12):1307-1313. doi: 10.1515/hsz-2016-0161.
7
Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.
Biol Chem. 2012 Apr;393(5):319-30. doi: 10.1515/hsz-2011-0273.
8
Regulation of human tissue kallikrein-related peptidase expression by steroid hormones in 32 cell lines.
Biol Chem. 2008 Nov;389(11):1409-19. doi: 10.1515/bc.2008.158.
9
The epigenetic basis for the aberrant expression of kallikreins in human cancers.
Biol Chem. 2006 Jun;387(6):795-9. doi: 10.1515/BC.2006.100.
10
The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions.
Biol Chem. 2001 Jan;382(1):5-14. doi: 10.1515/BC.2001.002.
引用本文的文献
1
Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer.
Biol Chem. 2016 Dec 1;397(12):1265-1276. doi: 10.1515/hsz-2016-0177.
2
Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Mol Cancer. 2015 May 20;14:107. doi: 10.1186/s12943-015-0381-6.
3
Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.
World J Gastroenterol. 2013 Dec 28;19(48):9425-31. doi: 10.3748/wjg.v19.i48.9425.
4
Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.
J Oncol. 2012;2012:737981. doi: 10.1155/2012/737981. Epub 2012 Feb 6.
5
Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.
Mol Oncol. 2011 Feb;5(1):48-60. doi: 10.1016/j.molonc.2010.08.002. Epub 2010 Aug 11.
6
Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.
Br J Cancer. 2010 Apr 13;102(8):1244-53. doi: 10.1038/sj.bjc.6605634. Epub 2010 Mar 30.
7
Functional roles of human kallikrein-related peptidases.
J Biol Chem. 2009 Nov 27;284(48):32989-94. doi: 10.1074/jbc.R109.027946. Epub 2009 Oct 9.
本文引用的文献
1
Distribution of 15 human kallikreins in tissues and biological fluids.
Clin Chem. 2007 Aug;53(8):1423-32. doi: 10.1373/clinchem.2007.088104. Epub 2007 Jun 15.
2
Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells.
Cancer Sci. 2007 Jul;98(7):1078-86. doi: 10.1111/j.1349-7006.2007.00495.x. Epub 2007 Apr 24.
3
The impact of translocations and gene fusions on cancer causation.
Nat Rev Cancer. 2007 Apr;7(4):233-45. doi: 10.1038/nrc2091. Epub 2007 Mar 15.
4
Human tissue kallikreins: the cancer biomarker family.
Cancer Lett. 2007 Apr 28;249(1):61-79. doi: 10.1016/j.canlet.2006.12.018. Epub 2007 Jan 31.
5
EGFRvIII mutation in lung cancer correlates with increased EGFR copy number.
Oncol Rep. 2007 Feb;17(2):319-23.
6
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
Cancer Cell. 2006 Dec;10(6):515-27. doi: 10.1016/j.ccr.2006.10.008.
7
Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias.
Cancer Genet Cytogenet. 2006 Sep;169(2):128-37. doi: 10.1016/j.cancergencyto.2006.04.003.
8
Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines.
Breast Cancer Res Treat. 2007 Mar;102(1):7-18. doi: 10.1007/s10549-006-9312-y. Epub 2006 Aug 8.
9
The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma.
Chromosoma. 2006 Dec;115(6):459-67. doi: 10.1007/s00412-006-0074-4. Epub 2006 Aug 9.
10
The epigenetic basis for the aberrant expression of kallikreins in human cancers.
Biol Chem. 2006 Jun;387(6):795-9. doi: 10.1515/BC.2006.100.
Zotero 插件